Experiences with
Tricor7 public posts
Fenofibrate could dramatically shorten the treatment time for severe COVID patients.
By MAAYAN JAFFE-HOFFMAN
AUGUST 23, 2021
Fourteen out of 15 severe COVID-19 patients who were treated in an investigator-initiated interventional open-label clinical study of the drug TriCor (fenofibrate) didn’t require oxygen support within a week of treatment and were released from the hospital,
Want to take advantage of all our features? Just log in!
or